Search research articles
Contact Us
Filters
Showing results (151-160 of 196) with videos related to
Page
of 20
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
December 23, 2024
Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmia
Daniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
Plos One
|
May 19, 2017
Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease
Chelsea Caspell-Garcia, Tanya Simuni, Duygu Tosun-Turgut, et al.
Neurology
|
January 13, 2026
CSF α-Synuclein Seed Amplification Assays and Skin Immunofluorescence: Clinical Applications, Research Opportunities, and Knowledge Gaps
David G Coughlin, Charles H Adler, William Barbosa, et al.
Annals of Neurology
|
May 14, 2026
Identification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker-Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative
Ethan G Brown, Lana M Chahine, Roseanne D Dobkin, et al.
JMIR Research Protocols
|
August 27, 2025
Improving Prediction of Falls and Cognitive Impairment in Parkinson Disease: Protocol for a Decentralized Observational Study
Audrey Hoyt, Casey Dorney, Peggy Auinger, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 4, 2021
Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease
Thomas Kremer, Kirsten I Taylor, Juliane Siebourg-Polster, et al.
The Lancet. Neurology
|
November 4, 2019
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
Tanya Simuni, Liz Uribe, Hyunkeun Ryan Cho, et al.
Annals of Neurology
|
July 11, 2025
Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder
Daniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
Annals of Clinical and Translational Neurology
|
December 15, 2020
Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder
Lana M Chahine, Michael C Brumm, Chelsea Caspell-Garcia, et al.
Frontiers in Neurology
|
October 18, 2021
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data
Gennaro Pagano, Frank G Boess, Kirsten I Taylor, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 196) with videos related to
Sort By:
Page
of 20
Medrxiv : the Preprint Server for Health Sciences
|
December 23, 2024
Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmia
Daniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
Plos One
|
May 19, 2017
Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease
Chelsea Caspell-Garcia, Tanya Simuni, Duygu Tosun-Turgut, et al.
Neurology
|
January 13, 2026
CSF α-Synuclein Seed Amplification Assays and Skin Immunofluorescence: Clinical Applications, Research Opportunities, and Knowledge Gaps
David G Coughlin, Charles H Adler, William Barbosa, et al.
Annals of Neurology
|
May 14, 2026
Identification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker-Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative
Ethan G Brown, Lana M Chahine, Roseanne D Dobkin, et al.
JMIR Research Protocols
|
August 27, 2025
Improving Prediction of Falls and Cognitive Impairment in Parkinson Disease: Protocol for a Decentralized Observational Study
Audrey Hoyt, Casey Dorney, Peggy Auinger, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 4, 2021
Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease
Thomas Kremer, Kirsten I Taylor, Juliane Siebourg-Polster, et al.
The Lancet. Neurology
|
November 4, 2019
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
Tanya Simuni, Liz Uribe, Hyunkeun Ryan Cho, et al.
Annals of Neurology
|
July 11, 2025
Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder
Daniel Weintraub, Anuprita R Nair, Ryan Kurth, et al.
Annals of Clinical and Translational Neurology
|
December 15, 2020
Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder
Lana M Chahine, Michael C Brumm, Chelsea Caspell-Garcia, et al.
Frontiers in Neurology
|
October 18, 2021
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data
Gennaro Pagano, Frank G Boess, Kirsten I Taylor, et al.
Page
of 20